HOME  |  CONTACT  

877-435-2524   


   

Come see us at the following 2007 Conferences and Symposiums


Multidisciplinary Head & Neck Cancer Symposium

The Westin Mission Hills, Rancho Mirage, CA

January 18-20, 2007

_______________________

ASBMT Transplant Nursing Conference

Keystone Resort, Keystone, CO

February 5-7, 2007

_______________________

Puget Sound ONS Symposium

Meydenbauer Convention Center, Bellevue, WA

March 16-18, 2007

_______________________

Oncology Nursing Society Congress (ONS)

Mandalay Bay Convention Center, Las Vegas, NV

April 24-27, 2007

_______________________

Alabama Society of Otolaryngology, Head and Neck Surgery

Sandestin Golf and Beach Resort, Destin, FL

June 15-17, 2007

 

 
3/27/08   EKR Therapeutics Appoints Co-Founder Richard DeSimone as COO
3/27/08   EKR Therapeutics Announces Management Additions and Promotions, Reflecting Support of Continued Acceleration in Growth
3/10/08   EKR Therapeutics Raises Over $145 Million in Support of Growth
2/04/08   EKR THERAPEUTICS AND PDL BIOPHARMA SIGN ASSET PURCHASE AGREEMENT FOR CARDIOVASCULAR PRODUCTS
10/22/07  

EKR Therapeutics Secures Credit Facility; Company Well Positioned to Strategically Pursue Product Acquisitions to Fuel Long-Term Growth Momentum

08/15/07  

EKR Therapeutics Achieves Key Growth Milestone with the Acquisition of Rights from Pacira Pharmaceuticals to DepoDurŽ, a Novel Extended-Release Opioid Analgesic for Post Operative Pain

08/15/07   EKR Therapeutics Raises Over $13 Million in a Series C Financing Round From New and Existing Investors
07/25/07   EKR Therapeutics Appoints Dr. Tong Zhang as Director of Business Development, Further Positioning the Company for Long-term Growth
06/04/07   EKR Therapeutics Expands Its Management Team in Support of Growth Momentum
04/09/07   EKR Therapeutics Launches www.Gelclair.com
02/12/07   EKR Therapeutics Expands Team
02/08/07   EKR Therapeutics expands board of directors with appointment of industry veteran Tony Scullion
10/12/06   EKR Therapeutics Acquires Exclusive License for GelclairŽ from Helsinn Healthcare SA
09/21/06   EKR Therapeutics Expands Management Team
06/27/06   ESP Pharma Founder Launches EKR Therapeutics with Financing Led by NewSpring Capital and ESP Equity Partners
08/05   EKR Therapeutics is Founded 
Company To Focus on Oncology Supportive Care Segment
   
       

 

 

About EKR Therapeutics, Inc.

EKR Therapeutics was founded to provide prescription products and therapeutic solutions that support and improve the quality of life of cancer patients. As new and increasingly effective therapies emerge, more patients survive cancer. Oncology supportive care is becoming an increasingly critical component in support of patients as they progress through the complex arena of oncology treatment. The management team of EKR believes that cancer survival is largely impacted by the appropriate management of side effects encountered by patients undergoing therapy. EKR Therapeutics is committed to collaborating with the full scope of healthcare practitioners in helping patients adhere to primary treatment through the use of supportive care products. 

Back to Top

 

About NewSpring Capital

NewSpring Capital, located in King of Prussia, PA and New York, NY, is a family of specific-purpose private equity funds, which includes NewSpring Ventures, L.P., a venture capital fund providing equity capital to growth and expansion stage companies with a focus on information technology, business services and health care; Commerce Health Ventures, L.P., a venture capital fund focused on intermediate-and-late stage life science and health care companies;  and NewSpring Mezzanine Capital, L.P., a regionally focused mezzanine debt fund that invests in information technology, business services, health care and specialty manufacturing. 

Back to Top

 

About ESP Equity Partners, LLC

ESP Equity Partners LLC is a private investment company that works closely with experienced local management teams to acquire pharmaceutical and medical assets in targeted therapeutic areas. ESP Equity is led by successful healthcare entrepreneurs with extensive international experience and a track record of sourcing undervalued products and executing deals in the US, Asia and South America.

Back to Top
 
For More Information, Contact:

Jennifer Zuccolo
EKR Therapeutics, Inc.
7 East Frederick Place
Cedar Knolls, NJ 07927
Ph. 877-435-2524

 

 
 
 

HOME | COMPANY | PRODUCTS |BUSINESS DEVELOPMENT | NEWS/EVENTSCONTACT  |  TERMS of USE